Hospitalized Exacerbations of COPD

医学 慢性阻塞性肺病 内科学 急诊医学 重症监护医学
作者
Hana Müllerová,Diego J. Maselli,Nicholas Locantore,Jørgen Vestbo,John R. Hurst,Jadwiga A. Wedzicha,Per Bakke,Àlvar Agustí,Antonio Anzueto
出处
期刊:Chest [Elsevier BV]
卷期号:147 (4): 999-1007 被引量:284
标识
DOI:10.1378/chest.14-0655
摘要

Exacerbations of COPD requiring hospital admission have important clinical and societal implications. We sought to investigate the incidence, recurrence, risk factors, and mortality of patients with COPD exacerbations requiring hospital admission compared with those without hospital admission during 3-year follow-up. Patients with COPD (N = 2,138) were identified from the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) observational cohort.An analysis of time to first event of hospital admission was performed using Kaplan-Meier curves and Cox proportional hazard regression adjusting for possible confounders.Of the 2,138 patients, 670 (31%) reported a total of 1,452 COPD exacerbations requiring hospital admission during the study period; 313 patients (15%) reported multiple events. A prior history of exacerbation of COPD requiring hospital admission was the factor associated with the highest risk of a new hospitalization for exacerbation (hazard ratio, 2.71; 95% CI, 2.24-3.29; P < .001). Other risk factors included more severe airflow limitation, poorer health status, older age, radiologic evidence of emphysema, and higher WBC count. Having been hospitalized for exacerbation significantly increased the risk of mortality (P < .001).Exacerbations of COPD requiring hospital admission occur across all stages of airflow limitation and are a significant prognostic factor of reduced survival across all COPD stages. Patients with COPD at a high risk for hospitalization can be identified by their past history for similar events, and other factors, including the severity of airflow limitation, poor health status, age, presence of emphysema, and leukocytosis.ClinicalTrials.gov; No.: NCT00292552; URL: www.clinicaltrials.gov.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
pumpkin完成签到,获得积分10
1秒前
ludov完成签到,获得积分10
1秒前
1秒前
cy完成签到,获得积分10
2秒前
3秒前
3秒前
zorro3574完成签到,获得积分10
4秒前
Xdz完成签到 ,获得积分10
5秒前
忐忑的凌丝完成签到,获得积分10
5秒前
5秒前
个性的翠芙完成签到 ,获得积分10
5秒前
皮蛋瘦肉周完成签到,获得积分10
6秒前
6秒前
SYLH应助木木采纳,获得30
6秒前
ZJR发布了新的文献求助10
6秒前
goodsheep完成签到 ,获得积分10
6秒前
Dr_Zhang完成签到,获得积分10
7秒前
烟花应助科研通管家采纳,获得30
7秒前
852应助科研通管家采纳,获得10
7秒前
wanci应助科研通管家采纳,获得10
7秒前
Akim应助科研通管家采纳,获得10
7秒前
NexusExplorer应助科研通管家采纳,获得10
7秒前
爆米花应助科研通管家采纳,获得10
7秒前
科研通AI2S应助科研通管家采纳,获得10
7秒前
上官若男应助科研通管家采纳,获得10
7秒前
7秒前
科目三应助科研通管家采纳,获得10
7秒前
白桃乌龙应助科研通管家采纳,获得10
8秒前
韩博完成签到,获得积分10
8秒前
赘婿应助科研通管家采纳,获得10
8秒前
8秒前
伍绮彤完成签到,获得积分10
8秒前
8秒前
雨寒发布了新的文献求助20
9秒前
weske发布了新的文献求助10
9秒前
11秒前
独特元蝶发布了新的文献求助10
13秒前
13秒前
Lucas应助陈陈采纳,获得10
14秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 1000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 310
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3979515
求助须知:如何正确求助?哪些是违规求助? 3523465
关于积分的说明 11217759
捐赠科研通 3260973
什么是DOI,文献DOI怎么找? 1800315
邀请新用户注册赠送积分活动 879017
科研通“疑难数据库(出版商)”最低求助积分说明 807144